VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q38641401 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000032.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q38641401‏
024 ‎‡a 0000-0001-8948-0650‏ ‎‡2 orcid‏
024 ‎‡a 7404216768‏ ‎‡2 scopus‏
024 ‎‡a 57189659933‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q38641401‏
043 ‎‡c US‏
046 ‎‡f 19550000‏
100 0 ‎‡a Stewart Anderson‏ ‎‡c American professor of biostatistics‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Stewart Anderson‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a স্টুয়ার্ট অ্যান্ডারসন‏ ‎‡c গবেষক‏ ‎‡9 bn‏
400 0 ‎‡a Stewart Anderson‏ ‎‡c Americký univerzitní profesor biostatistiky. Publikace z oboru.‏ ‎‡9 cs‏
400 0 ‎‡a Stewart Anderson‏ ‎‡c hulumtues‏ ‎‡9 sq‏
670 ‎‡a Author's A comparison of principal component analysis and factor analysis strategies for uncovering pleiotropic factors‏
670 ‎‡a Author's A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study‏
670 ‎‡a Author's A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.‏
670 ‎‡a Author's A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma‏
670 ‎‡a Author's A stochastic multiple imputation algorithm for missing covariate data in tree-structured survival analysis.‏
670 ‎‡a Author's A three-step estimation procedure using local polynomial smoothing for inconsistently sampled longitudinal data‏
670 ‎‡a Author's Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience‏
670 ‎‡a Author's Additive effect of age on disability for individuals with spinal cord injuries.‏
670 ‎‡a Author's Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials‏
670 ‎‡a Author's Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.‏
670 ‎‡a Author's An adaptive two-stage dose-response design method for establishing proof of concept‏
670 ‎‡a Author's Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults‏
670 ‎‡a Author's Association of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon Treatment‏
670 ‎‡a Author's Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.‏
670 ‎‡a Author's Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.‏
670 ‎‡a Author's Breast cancer trials on trial: a case of conflicting ethical interests.‏
670 ‎‡a Author's Characterization of the effects of an airborne mixture of chemicals on the respiratory tract and smoothing polynomial spline analysis of the data.‏
670 ‎‡a Author's Chemotherapy for isolated locoregional recurrence of breast cancer‏
670 ‎‡a Author's Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.‏
670 ‎‡a Author's Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder‏
670 ‎‡a Author's Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial‏
670 ‎‡a Author's Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.‏
670 ‎‡a Author's Conservative management of intraductal carcinoma‏
670 ‎‡a Author's Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators‏
670 ‎‡a Author's Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project‏
670 ‎‡a Author's Correlates of quantitative ultrasound in the Women's Healthy Lifestyle Project‏
670 ‎‡a Author's Craving in intermittent and daily smokers during ad libitum smoking‏
670 ‎‡a Author's Cue reactivity in converted and native intermittent smokers‏
670 ‎‡a Author's Cue reactivity in non-daily smokers: effects on craving and on smoking behavior‏
670 ‎‡a Author's Declines in mobility and changes in performance in the instrumental activities of daily living among mildly disabled community-dwelling older adults‏
670 ‎‡a Author's Design and Implementation of an Intervention Development Study: Retaining Cognition While Avoiding Late-Life Depression (ReCALL).‏
670 ‎‡a Author's Design and Recruitment for a Randomized Controlled Trial of Problem-Solving Therapy to Prevent Depression among Older Adults with Need for Supportive Services.‏
670 ‎‡a Author's Early intervention to preempt major depression among older black and white adults‏
670 ‎‡a Author's Early intervention to reduce the global health and economic burden of major depression in older adults‏
670 ‎‡a Author's Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer‏
670 ‎‡a Author's Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial‏
670 ‎‡a Author's Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer‏
670 ‎‡a Author's Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.‏
670 ‎‡a Author's Intervention development for the indicated prevention of depression in later life: the "DIL" protocol in Goa, India.‏
670 ‎‡a Author's Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.‏
670 ‎‡a Author's Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder‏
670 ‎‡a Author's Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy‏
670 ‎‡a Author's Measuring Participant Effort in a Depression Prevention Trial: Who Engages in Problem-Solving Therapy?‏
670 ‎‡a Author's Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.‏
670 ‎‡a Author's Neuropsychological functioning in the acute and remitted States of late-life depression‏
670 ‎‡a Author's NONPARAMETRIC MANOVA APPROACHES FOR NON-NORMAL MULTIVARIATE OUTCOMES WITH MISSING VALUES.‏
670 ‎‡a Author's Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.‏
670 ‎‡a Author's Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.‏
670 ‎‡a Author's Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random‏
670 ‎‡a Author's Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.‏
670 ‎‡a Author's Prediction of transplant-free survival in idiopathic pulmonary fibrosis patients using joint models for event times and mixed multivariate longitudinal data‏
670 ‎‡a Author's Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.‏
670 ‎‡a Author's Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.‏
670 ‎‡a Author's Preliminary results of centralized HER2 testing in ductal carcinoma in situ‏
670 ‎‡a Author's Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43‏
670 ‎‡a Author's Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.‏
670 ‎‡a Author's Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials‏
670 ‎‡a Author's Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer‏
670 ‎‡a Author's Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer.‏
670 ‎‡a Author's Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer‏
670 ‎‡a Author's Reply to M. R. Van Bockstal et al‏
670 ‎‡a Author's Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study‏
670 ‎‡a Author's Sample size determination in complex clinical trials comparing more than two groups for survival endpoints‏
670 ‎‡a Author's Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial‏
670 ‎‡a Author's Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.‏
670 ‎‡a Author's Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27‏
670 ‎‡a Author's Significance of ipsilateral breast tumour recurrence after lumpectomy‏
670 ‎‡a Author's Smoking patterns and stimulus control in intermittent and daily smokers‏
670 ‎‡a Author's Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma‏
670 ‎‡a Author's Some thoughts on the reporting of adverse events in phase II cancer clinical trials‏
670 ‎‡a Author's Stability of family interaction from ages 6 to 18.‏
670 ‎‡a Author's Statistical concepts and biomedical research‏
670 ‎‡a Author's Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial‏
670 ‎‡a Author's The breast cancer alternative hypothesis: is there evidence to justify replacing it?‏
670 ‎‡a Author's The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.‏
670 ‎‡a Author's Trajectories of suicidal ideation in depressed older adults undergoing antidepressant treatment‏
670 ‎‡a Author's Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.‏
670 ‎‡a Author's Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.‏
670 ‎‡a Author's Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.‏
670 ‎‡a Author's Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.‏
670 ‎‡a Author's Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?‏
670 ‎‡a Author's Using smoothing splines to make inferences about the shape of gas-exchange curves‏
670 ‎‡a Author's Using trajectories from a bivariate growth curve as predictors in a Cox regression model‏
670 ‎‡a Author's Zero inflation in ordinal data: incorporating susceptibility to response through the use of a mixture model.‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/DNB|102012413X‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/NUKAT|n 2012152925‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/ISNI|0000000362049873‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/viaf/221820057‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/NKC|jcu2012691861‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/SUDOC|166035068‏
909 ‎‡a (orcid) 0000000189480650‏ ‎‡9 1‏
909 ‎‡a (scopus) 7404216768‏ ‎‡9 1‏
909 ‎‡a (scopus) 57189659933‏ ‎‡9 1‏
919 ‎‡a comparisonofprincipalcomponentanalysisandfactoranalysisstrategiesforuncoveringpleiotropicfactors‏ ‎‡A A comparison of principal component analysis and factor analysis strategies for uncovering pleiotropic factors‏ ‎‡9 1‏
919 ‎‡a contemporaryestimateoftotalmortalityandcardiovasculardiseaseriskinyoungadultswithtype1diabetesthepittsburghepidemiologyofdiabetescomplicationsstudy‏ ‎‡A A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study‏ ‎‡9 1‏
919 ‎‡a randomizedclinicaltrialofadjuvantchemotherapyforradicallyresectedlocoregionalrelapseofbreastcanceribcsg2702big102andnsabpb37‏ ‎‡A A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.‏ ‎‡9 1‏
919 ‎‡a randomizedstudywosmm1comparingtheoralregimezdexidarubicinanddexamethasonewithvincristineadriamycinanddexamethasoneasinductiontherapyfornewlydiagnosedpatientswithmultiplemyeloma‏ ‎‡A A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma‏ ‎‡9 1‏
919 ‎‡a stochasticmultipleimputationalgorithmformissingcovariatedataintreestructuredsurvivalanalysis‏ ‎‡A A stochastic multiple imputation algorithm for missing covariate data in tree-structured survival analysis.‏ ‎‡9 1‏
919 ‎‡a 3stepestimationprocedureusinglocalpolynomialsmoothingforinconsistentlysampledlongitudinaldata‏ ‎‡A A three-step estimation procedure using local polynomial smoothing for inconsistently sampled longitudinal data‏ ‎‡9 1‏
919 ‎‡a acutemyeloidleukemiaandmyelodysplasticsyndromeafterdoxorubicincyclophosphamideadjuvanttherapyforoperablebreastcancerthenationalsurgicaladjuvantbreastandbowelprojectexperience‏ ‎‡A Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience‏ ‎‡9 1‏
919 ‎‡a additiveeffectofageondisabilityforindividualswithspinalcordinjuries‏ ‎‡A Additive effect of age on disability for individuals with spinal cord injuries.‏ ‎‡9 1‏
919 ‎‡a adjuvantbisphosphonatetreatmentinearlybreastcancermetaanalysesofindividualpatientdatafromrandomisedtrials‏ ‎‡A Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials‏ ‎‡9 1‏
919 ‎‡a adjuvanttamoxifenreducessubsequentbreastcancerinwomenwithestrogenreceptorpositiveductalcarcinomainsituastudybasedonnsabpprotocolb24‏ ‎‡A Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.‏ ‎‡9 1‏
919 ‎‡a adaptive2stagedoseresponsedesignmethodforestablishingproofofconcept‏ ‎‡A An adaptive two-stage dose-response design method for establishing proof of concept‏ ‎‡9 1‏
919 ‎‡a antidepressantresponsetrajectoriesandassociatedclinicalprognosticfactorsamongolderadults‏ ‎‡A Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults‏ ‎‡9 1‏
919 ‎‡a associationofbaselinesleepqualitywithtrajectoriesofdepressivesymptomsinpatientsundergoinginterferontreatment‏ ‎‡A Association of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon Treatment‏ ‎‡9 1‏
919 ‎‡a bodymassindexatdiagnosisandbreastcancersurvivalprognosisinclinicaltrialpopulationsfromnrgoncologynsabpb30b31b34andb38‏ ‎‡A Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.‏ ‎‡9 1‏
919 ‎‡a brainderivedneurotrophicfactorlevelsinlatelifedepressionandcomorbidmildcognitiveimpairmentalongitudinalstudy‏ ‎‡A Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.‏ ‎‡9 1‏
919 ‎‡a breastcancertrialsontrialacaseofconflictingethicalinterests‏ ‎‡A Breast cancer trials on trial: a case of conflicting ethical interests.‏ ‎‡9 1‏
919 ‎‡a characterizationoftheeffectsofanairbornemixtureofchemicalsontherespiratorytractandsmoothingpolynomialsplineanalysisofthedata‏ ‎‡A Characterization of the effects of an airborne mixture of chemicals on the respiratory tract and smoothing polynomial spline analysis of the data.‏ ‎‡9 1‏
919 ‎‡a chemotherapyforisolatedlocoregionalrecurrenceofbreastcancer‏ ‎‡A Chemotherapy for isolated locoregional recurrence of breast cancer‏ ‎‡9 1‏
919 ‎‡a chemotherapyforisolatedlocoregionalrecurrenceofbreastcancercalorarandomisedtrial‏ ‎‡A Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.‏ ‎‡9 1‏
919 ‎‡a combiningmoderatorstoidentifyclinicalprofilesofpatientswhowillandwillnotbenefitfromaripiprazoleaugmentationfortreatmentresistantlatelifemajordepressivedisorder‏ ‎‡A Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder‏ ‎‡9 1‏
919 ‎‡a comparisonofradiationwithorwithoutconcurrenttrastuzumabforher2positiveductalcarcinomainsituresectedbylumpectomyaphase3clinicaltrial‏ ‎‡A Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial‏ ‎‡9 1‏
919 ‎‡a comparisonoftheprognosticandpredictiveutilitiesofthe21generecurrencescoreassayandadjuvantforwomenwithnodenegativeerpositivebreastcancerresultsfromnsabpb14andnsabpb20‏ ‎‡A Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.‏ ‎‡9 1‏
919 ‎‡a conservativemanagementofintraductalcarcinoma‏ ‎‡A Conservative management of intraductal carcinoma‏ ‎‡9 1‏
919 ‎‡a conservativemanagementofintraductalcarcinomadcisofthebreastcollaboratingnsabpinvestigators‏ ‎‡A Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators‏ ‎‡9 1‏
919 ‎‡a conservativesurgeryforthemanagementofinvasiveandnoninvasivecarcinomaofthebreastnsabptrialsnationalsurgicaladjuvantbreastandbowelproject‏ ‎‡A Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project‏ ‎‡9 1‏
919 ‎‡a correlatesofquantitativeultrasoundinthewomenshealthylifestyleproject‏ ‎‡A Correlates of quantitative ultrasound in the Women's Healthy Lifestyle Project‏ ‎‡9 1‏
919 ‎‡a cravinginintermittentanddailysmokersduringadlibitumsmoking‏ ‎‡A Craving in intermittent and daily smokers during ad libitum smoking‏ ‎‡9 1‏
919 ‎‡a cuereactivityinconvertedandnativeintermittentsmokers‏ ‎‡A Cue reactivity in converted and native intermittent smokers‏ ‎‡9 1‏
919 ‎‡a cuereactivityinnondailysmokerseffectsoncravingandonsmokingbehavior‏ ‎‡A Cue reactivity in non-daily smokers: effects on craving and on smoking behavior‏ ‎‡9 1‏
919 ‎‡a declinesinmobilityandchangesinperformanceintheinstrumentalactivitiesofdailylivingamongmildlydisabledcommunitydwellingolderadults‏ ‎‡A Declines in mobility and changes in performance in the instrumental activities of daily living among mildly disabled community-dwelling older adults‏ ‎‡9 1‏
919 ‎‡a designandimplementationofaninterventiondevelopmentstudyretainingcognitionwhileavoidinglatelifedepressionrecall‏ ‎‡A Design and Implementation of an Intervention Development Study: Retaining Cognition While Avoiding Late-Life Depression (ReCALL).‏ ‎‡9 1‏
919 ‎‡a designandrecruitmentforarandomizedcontrolledtrialofproblemsolvingtherapytopreventdepressionamongolderadultswithneedforsupportiveservices‏ ‎‡A Design and Recruitment for a Randomized Controlled Trial of Problem-Solving Therapy to Prevent Depression among Older Adults with Need for Supportive Services.‏ ‎‡9 1‏
919 ‎‡a earlyinterventiontopreemptmajordepressionamongolderblackandwhiteadults‏ ‎‡A Early intervention to preempt major depression among older black and white adults‏ ‎‡9 1‏
919 ‎‡a earlyinterventiontoreducetheglobalhealthandeconomicburdenofmajordepressioninolderadults‏ ‎‡A Early intervention to reduce the global health and economic burden of major depression in older adults‏ ‎‡9 1‏
919 ‎‡a effectsofobesityandraceonprognosisinlymphnodenegativeestrogenreceptornegativebreastcancer‏ ‎‡A Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer‏ ‎‡9 1‏
919 ‎‡a efficacysafetyandtolerabilityofaugmentationpharmacotherapywitharipiprazolefortreatmentresistantdepressioninlatelifearandomiseddoubleblindplacebocontrolledtrial‏ ‎‡A Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial‏ ‎‡9 1‏
919 ‎‡a hazardofrecurrenceandadjuvanttreatmenteffectsovertimeinlymphnodenegativebreastcancer‏ ‎‡A Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer‏ ‎‡9 1‏
919 ‎‡a healthrelatedqualityoflifeinaxillarynodenegativeestrogenreceptornegativebreastcancerpatientsundergoingacversuscmfchemotherapyfindingsfromthenationalsurgicaladjuvantbreastandbowelprojectb23‏ ‎‡A Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.‏ ‎‡9 1‏
919 ‎‡a interventiondevelopmentfortheindicatedpreventionofdepressioninlaterlifethedilprotocolingoaindia‏ ‎‡A Intervention development for the indicated prevention of depression in later life: the "DIL" protocol in Goa, India.‏ ‎‡9 1‏
919 ‎‡a longtermoutcomesofinvasiveipsilateralbreasttumorrecurrencesafterlumpectomyinnsabpb17andb24randomizedclinicaltrialsfordcis‏ ‎‡A Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.‏ ‎‡9 1‏
919 ‎‡a longerlithiumexposureisassociatedwithbetterwhitematterintegrityinolderadultswithbipolardisorder‏ ‎‡A Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder‏ ‎‡9 1‏
919 ‎‡a maintenancetreatmentofdepressioninoldagearandomizeddoubleblindplacebocontrolledevaluationoftheefficacyandsafetyofdonepezilcombinedwithantidepressantpharmacotherapy‏ ‎‡A Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy‏ ‎‡9 1‏
919 ‎‡a measuringparticipanteffortinadepressionpreventiontrialwhoengagesinproblemsolvingtherapy‏ ‎‡A Measuring Participant Effort in a Depression Prevention Trial: Who Engages in Problem-Solving Therapy?‏ ‎‡9 1‏
919 ‎‡a morbidityresultsfromthensabpb32trialcomparingsentinellymphnodedissectionversusaxillarydissection‏ ‎‡A Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.‏ ‎‡9 1‏
919 ‎‡a neuropsychologicalfunctioningintheacuteandremittedstatesoflatelifedepression‏ ‎‡A Neuropsychological functioning in the acute and remitted States of late-life depression‏ ‎‡9 1‏
919 ‎‡a nonparametricmanovaapproachesfornonnormalmultivariateoutcomeswithmissingvalues‏ ‎‡A NONPARAMETRIC MANOVA APPROACHES FOR NON-NORMAL MULTIVARIATE OUTCOMES WITH MISSING VALUES.‏ ‎‡9 1‏
919 ‎‡a oralclodronateforadjuvanttreatmentofoperablebreastcancernationalsurgicaladjuvantbreastandbowelprojectprotocolb34amulticentreplacebocontrolledrandomisedtrial‏ ‎‡A Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.‏ ‎‡9 1‏
919 ‎‡a patientreportedoutcomesinsentinelnodenegativeadjuvantbreastcancerpatientsreceivingsentinelnodebiopsyoraxillarydissectionnationalsurgicaladjuvantbreastandbowelprojectphase3protocolb32‏ ‎‡A Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.‏ ‎‡9 1‏
919 ‎‡a patternsoflocoregionalfailureinpatientswithoperablebreastcancertreatedbymastectomyandadjuvantchemotherapywithorwithouttamoxifenandwithoutradiotherapyresultsfrom5nationalsurgicaladjuvantbreastandbowelprojectrandom‏ ‎‡A Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random‏ ‎‡9 1‏
919 ‎‡a poorprognosisafter2locoregionalrecurrencesinthecalortrial‏ ‎‡A Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.‏ ‎‡9 1‏
919 ‎‡a predictionoftransplantfreesurvivalinidiopathicpulmonaryfibrosispatientsusingjointmodelsforeventtimesandmixedmultivariatelongitudinaldata‏ ‎‡A Prediction of transplant-free survival in idiopathic pulmonary fibrosis patients using joint models for event times and mixed multivariate longitudinal data‏ ‎‡9 1‏
919 ‎‡a predictorsandmoderatorsofremissionwitharipiprazoleaugmentationintreatmentresistantlatelifedepressionananalysisoftheirlgreyrandomizedclinicaltrial‏ ‎‡A Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.‏ ‎‡9 1‏
919 ‎‡a predictorsoflocoregionalrecurrenceafterneoadjuvantchemotherapyresultsfromcombinedanalysisofnationalsurgicaladjuvantbreastandbowelprojectb18andb27‏ ‎‡A Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.‏ ‎‡9 1‏
919 ‎‡a preliminaryresultsofcentralizedher2testinginductalcarcinomainsitu‏ ‎‡A Preliminary results of centralized HER2 testing in ductal carcinoma in situ‏ ‎‡9 1‏
919 ‎‡a preliminaryresultsofcentralizedher2testinginductalcarcinomainsitudcisnsabpb43‏ ‎‡A Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43‏ ‎‡9 1‏
919 ‎‡a preoperativechemotherapyupdatesofnationalsurgicaladjuvantbreastandbowelprojectprotocolsb18andb27‏ ‎‡A Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.‏ ‎‡9 1‏
919 ‎‡a prognosisafteripsilateralbreasttumorrecurrenceandlocoregionalrecurrencesin5nationalsurgicaladjuvantbreastandbowelprojectnodepositiveadjuvantbreastcancertrials‏ ‎‡A Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials‏ ‎‡9 1‏
919 ‎‡a prognosisafteripsilateralbreasttumorrecurrenceandlocoregionalrecurrencesinpatientstreatedbybreastconservingtherapyin5nationalsurgicaladjuvantbreastandbowelprojectprotocolsofnodenegativebreastcancer‏ ‎‡A Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer‏ ‎‡9 1‏
919 ‎‡a progressonbig102ibcsg2702nsabpb37aprospectiverandomizedtrialevaluatingchemotherapyafterlocaltherapyforisolatedlocoregionalrecurrencesofbreastcancer‏ ‎‡A Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer.‏ ‎‡9 1‏
919 ‎‡a reanalysisandresultsafter12yearsoffollowupinarandomizedclinicaltrialcomparingtotalmastectomywithlumpectomywithorwithoutirradiationinthetreatmentofbreastcancer‏ ‎‡A Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer‏ ‎‡9 1‏
919 ‎‡a replyto1000rvanbockstaletal‏ ‎‡A Reply to M. R. Van Bockstal et al‏ ‎‡9 1‏
919 ‎‡a riskstratificationfor25yearcardiovasculardiseaseincidenceintype1diabetestreestructuredsurvivalanalysisofthepittsburghepidemiologyofdiabetescomplicationsstudy‏ ‎‡A Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study‏ ‎‡9 1‏
919 ‎‡a samplesizedeterminationincomplexclinicaltrialscomparingmorethan2groupsforsurvivalendpoints‏ ‎‡A Sample size determination in complex clinical trials comparing more than two groups for survival endpoints‏ ‎‡9 1‏
919 ‎‡a sentinellymphnoderesectioncomparedwithconventionalaxillarylymphnodedissectioninclinicallynodenegativepatientswithbreastcanceroverallsurvivalfindingsfromthensabpb32randomisedphase3trial‏ ‎‡A Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial‏ ‎‡9 1‏
919 ‎‡a sentinelnodebiopsyafterneoadjuvantchemotherapyinbreastcancerresultsfromnationalsurgicaladjuvantbreastandbowelprojectprotocolb27‏ ‎‡A Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.‏ ‎‡9 1‏
919 ‎‡a sequentialpreoperativeorpostoperativedocetaxeladdedtopreoperativedoxorubicinpluscyclophosphamideforoperablebreastcancernationalsurgicaladjuvantbreastandbowelprojectprotocolb27‏ ‎‡A Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27‏ ‎‡9 1‏
919 ‎‡a significanceofipsilateralbreasttumourrecurrenceafterlumpectomy‏ ‎‡A Significance of ipsilateral breast tumour recurrence after lumpectomy‏ ‎‡9 1‏
919 ‎‡a smokingpatternsandstimuluscontrolinintermittentanddailysmokers‏ ‎‡A Smoking patterns and stimulus control in intermittent and daily smokers‏ ‎‡9 1‏
919 ‎‡a solvingthedilemmaoftheimmunohistochemicalandothermethodsusedforscoringestrogenreceptorandprogesteronereceptorinpatientswithinvasivebreastcarcinoma‏ ‎‡A Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma‏ ‎‡9 1‏
919 ‎‡a somethoughtsonthereportingofadverseeventsinphase2cancerclinicaltrials‏ ‎‡A Some thoughts on the reporting of adverse events in phase II cancer clinical trials‏ ‎‡9 1‏
919 ‎‡a stabilityoffamilyinteractionfromages6to18‏ ‎‡A Stability of family interaction from ages 6 to 18.‏ ‎‡9 1‏
919 ‎‡a statisticalconceptsandbiomedicalresearch‏ ‎‡A Statistical concepts and biomedical research‏ ‎‡9 1‏
919 ‎‡a technicaloutcomesofsentinellymphnoderesectionandconventionalaxillarylymphnodedissectioninpatientswithclinicallynodenegativebreastcancerresultsfromthensabpb32randomisedphase3trial‏ ‎‡A Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial‏ ‎‡9 1‏
919 ‎‡a breastcanceralternativehypothesisisthereevidencetojustifyreplacingit‏ ‎‡A The breast cancer alternative hypothesis: is there evidence to justify replacing it?‏ ‎‡9 1‏
919 ‎‡a effectontumorresponseofaddingsequentialpreoperativedocetaxeltopreoperativedoxorubicinandcyclophosphamidepreliminaryresultsfromnationalsurgicaladjuvantbreastandbowelprojectprotocolb27‏ ‎‡A The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.‏ ‎‡9 1‏
919 ‎‡a trajectoriesofsuicidalideationindepressedolderadultsundergoingantidepressanttreatment‏ ‎‡A Trajectories of suicidal ideation in depressed older adults undergoing antidepressant treatment‏ ‎‡9 1‏
919 ‎‡a treatmentofaxillarylymphnodenegativeestrogenreceptornegativebreastcancerupdatedfindingsfromnationalsurgicaladjuvantbreastandbowelprojectclinicaltrials‏ ‎‡A Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.‏ ‎‡9 1‏
919 ‎‡a treatmentoflymphnodenegativeoestrogenreceptorpositivebreastcancerlongtermfindingsfromnationalsurgicaladjuvantbreastandbowelprojectrandomisedclinicaltrials‏ ‎‡A Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.‏ ‎‡9 1‏
919 ‎‡a 205yearfollowupofarandomizedtrialcomparingradicalmastectomytotalmastectomyandtotalmastectomyfollowedbyirradiation‏ ‎‡A Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.‏ ‎‡9 1‏
919 ‎‡a 20yearfollowupofarandomizedtrialcomparingtotalmastectomylumpectomyandlumpectomyplusirradiationforthetreatmentofinvasivebreastcancer‏ ‎‡A Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.‏ ‎‡9 1‏
919 ‎‡a 2yearcourseofcognitivefunctionandinstrumentalactivitiesofdailylivinginolderadultswithbipolardisorderevidenceforneuroprogression‏ ‎‡A Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?‏ ‎‡9 1‏
919 ‎‡a usingsmoothingsplinestomakeinferencesabouttheshapeofgasexchangecurves‏ ‎‡A Using smoothing splines to make inferences about the shape of gas-exchange curves‏ ‎‡9 1‏
919 ‎‡a usingtrajectoriesfromabivariategrowthcurveaspredictorsinacoxregressionmodel‏ ‎‡A Using trajectories from a bivariate growth curve as predictors in a Cox regression model‏ ‎‡9 1‏
919 ‎‡a 0inflationinordinaldataincorporatingsusceptibilitytoresponsethroughtheuseofamixturemodel‏ ‎‡A Zero inflation in ordinal data: incorporating susceptibility to response through the use of a mixture model.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
947 ‎‡a US‏ ‎‡9 1‏
996 ‎‡2 LC|n 85804473‏
996 ‎‡2 ISNI|0000000027717088‏
996 ‎‡2 NUKAT|n 2018133252‏
996 ‎‡2 DBC|87097990066757‏
996 ‎‡2 NKC|jo2012692615‏
996 ‎‡2 SUDOC|175441669‏
996 ‎‡2 J9U|987007276491905171‏
996 ‎‡2 NUKAT|n 2013046554‏
996 ‎‡2 ISNI|0000000362049873‏
996 ‎‡2 NTA|070898758‏
996 ‎‡2 DNB|123987709‏
996 ‎‡2 CAOONL|ncf10457223‏
996 ‎‡2 ISNI|0000000082810541‏
996 ‎‡2 DNB|1089425341‏
996 ‎‡2 CAOONL|ncf11344294‏
996 ‎‡2 BIBSYS|5091700‏
996 ‎‡2 LC|n 86808264‏
996 ‎‡2 SUDOC|241336996‏
996 ‎‡2 BNF|17851512‏
996 ‎‡2 BIBSYS|3087193‏
996 ‎‡2 CAOONL|ncf10371195‏
996 ‎‡2 SUDOC|192460099‏
996 ‎‡2 NUKAT|n 2012214586‏
996 ‎‡2 SUDOC|07787286X‏
996 ‎‡2 J9U|987012330237805171‏
996 ‎‡2 CAOONL|ncf10142790‏
996 ‎‡2 ISNI|0000000067127840‏
996 ‎‡2 NUKAT|n 01715174‏
996 ‎‡2 W2Z|1701935244485‏
996 ‎‡2 DNB|1025794931‏
996 ‎‡2 SUDOC|26308258X‏
996 ‎‡2 DNB|123738849X‏
996 ‎‡2 BNF|17835496‏
996 ‎‡2 LC|no2017156020‏
996 ‎‡2 LC|n 2010182046‏
996 ‎‡2 LC|n 2012003010‏
996 ‎‡2 BIBSYS|10039423‏
996 ‎‡2 DNB|1158200951‏
996 ‎‡2 CAOONL|ncf10109853‏
996 ‎‡2 SZ|123738849X‏
996 ‎‡2 ISNI|0000000025363888‏
996 ‎‡2 J9U|987007374011605171‏
996 ‎‡2 BIBSYS|3045600‏
996 ‎‡2 ISNI|0000000029839636‏
996 ‎‡2 LC|no2019060268‏
996 ‎‡2 RERO|A002928590‏
996 ‎‡2 RERO|A002928591‏
996 ‎‡2 CAOONL|ncf10991942‏
996 ‎‡2 ISNI|000000049712157X‏
996 ‎‡2 NII|DA01364068‏
996 ‎‡2 BIBSYS|1701935244485‏
996 ‎‡2 DNB|115735730X‏
996 ‎‡2 ISNI|000000003398529X‏
996 ‎‡2 LC|n 80112421‏
996 ‎‡2 LC|n 82035178‏
996 ‎‡2 SUDOC|166035068‏
996 ‎‡2 LC|n 2002153796‏
996 ‎‡2 LC|n 2015180511‏
996 ‎‡2 LC|n 88281326‏
996 ‎‡2 ISNI|0000000363264700‏
996 ‎‡2 LC|no2003030673‏
996 ‎‡2 LC|nb2019017292‏
996 ‎‡2 ISNI|0000000480024482‏
996 ‎‡2 ISNI|0000000028914534‏
996 ‎‡2 J9U|987007358943205171‏
996 ‎‡2 SUDOC|229598951‏
996 ‎‡2 BNC|981058526457406706‏
996 ‎‡2 DNB|108916677X‏
996 ‎‡2 NTA|099738597‏
996 ‎‡2 DNB|102012413X‏
996 ‎‡2 LC|n 85058267‏
996 ‎‡2 SUDOC|083285865‏
996 ‎‡2 NKC|jcu2012691861‏
996 ‎‡2 LC|n 86130611‏
996 ‎‡2 RERO|A011383594‏
996 ‎‡2 SUDOC|143143840‏
996 ‎‡2 RERO|A021936100‏
996 ‎‡2 ISNI|0000000456519258‏
996 ‎‡2 BIBSYS|98019719‏
996 ‎‡2 LC|no2006104366‏
996 ‎‡2 LC|no2019138078‏
996 ‎‡2 NUKAT|n 2012152925‏
996 ‎‡2 CAOONL|ncf10540330‏
996 ‎‡2 CAOONL|ncf10431079‏
996 ‎‡2 N6I|vtls002177651‏
996 ‎‡2 BIBSYS|14068816‏
996 ‎‡2 BIBSYS|90094180‏
996 ‎‡2 J9U|987012726345305171‏
996 ‎‡2 BIBSYS|99004521‏
996 ‎‡2 LC|n 79133566‏
997 ‎‡a 1955 0 lived 0000 0‏ ‎‡9 1‏
998 ‎‡a Anderson, Stewart‏ ‎‡2 DNB|102012413X‏ ‎‡3 suggested‏
998 ‎‡a Anderson, Stewart‏ ‎‡2 ISNI|0000000362049873‏ ‎‡3 suggested‏
998 ‎‡a Anderson, Stewart‏ ‎‡2 ISNI|0000000362049873‏ ‎‡3 suggested‏
998 ‎‡a Anderson, Stewart‏ ‎‡2 ISNI|0000000362049873‏ ‎‡3 suggested‏
998 ‎‡a Anderson, Stewart,‏ ‎‡2 SUDOC|166035068‏ ‎‡3 suggested‏ ‎‡3 single date‏
998 ‎‡a Anderson, Stewart,‏ ‎‡2 NKC|jcu2012691861‏ ‎‡3 suggested‏
998 ‎‡a Anderson, Stewart,‏ ‎‡2 RERO|A021936100‏ ‎‡3 single date‏
998 ‎‡a Anderson, Stewart‏ ‎‡2 NUKAT|n 2012152925‏ ‎‡3 suggested‏ ‎‡3 viafid‏